作者
Ilan Merdler, Brian Case, Sukhdeep Bhogal, Pavan K Reddy, Vaishnavi Sawant, Cheng Zhang, Syed Ali, Itsik Ben-Dor, Lowell F Satler, Toby Rogers, Ron Waksman
发表日期
2023/11/1
期刊
Cardiovascular Revascularization Medicine
卷号
56
页码范围
1-6
出版商
Elsevier
简介
Background
The Evolut FX system is the most recent generation of self-expandable transcatheter heart valve (THV) technology. This study aims to report the early experience and outcomes associated with this system.
Methods
Our analysis included 200 consecutive patients who underwent transcatheter aortic valve replacement at our center from 2022 to 2023. The first cohort comprised the last 100 patients who received the Evolut PRO+ THV, while the second cohort included the first 100 patients who received the Evolut FX THV. The primary endpoints of the study were defined according to the Valve Academic Research Consortium-3 (VARC-3) criteria, which included technical success (at exit from procedure), device success (at discharge or at 30 days), and early safety (at 30 days).
Results
The study groups demonstrated no significant differences in baseline characteristics, including co-morbidities, pre-procedural …
学术搜索中的文章
I Merdler, B Case, S Bhogal, PK Reddy, V Sawant… - Cardiovascular Revascularization Medicine, 2023